Belvedere Trading LLC Aldeyra Therapeutics, Inc. Put Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 08, 2023	SELL	$7.11 - $11.89 $169,218 - $282,982	-23,800 Reduced 68.39%	11,000 $92,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $200,795 - $345,564	34,800 New	34,800 $345,000
Q3 2021 Oct 19, 2021	BUY	$7.94 - $11.31 $94,486 - $134,589	11,900 New	11,900 $100,000
Q2 2021 Jul 23, 2021	SELL	$10.44 - $14.85 $135,720 - $193,050	-13,000 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$6.53 - $14.42 $84,890 - $187,460	13,000 New	13,000 $154,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.